Lupin gets USFDA nod for primary biliary cholangitis drug Obeticholic Acid Ruchika Sharma24 March 2023 2:00 PM ISTMumbai: Global pharma major, Lupin Limited, has announced that the company has received tentative approval from the United States Food and Drug...
Obeticholic acid linked to better transplant-free survival in primary biliary cholangitis: Study Dr. Kamal Kant Kohli6 Dec 2022 10:00 AM ISTUK: As per a study employing individuals from the randomized POISE trial that was published in the journal Gastroenterology, patients suffering from...
Intercept Pharma resolves patent dispute with Dr Reddys Labs over generic Ocaliva Ruchika Sharma19 Aug 2022 3:03 PM ISTHyderabad: Intercept Pharmaceuticals Inc has said it entered into a settlement agreement with Dr Reddy's Laboratories resolving the previously...
Seladelpar effectively reduces alkaline phosphatase levels in patients with primary biliary cholangitis Dr. Shravani Dali17 Aug 2022 8:00 PM ISTSeladelpar showed dose-dependent efficacy in the reduction of alkaline phosphatase levels in patients with primary biliary cholangitis according to a...
Intercept to go back to USFDA with its NASH treatment application Ruchika Sharma10 July 2022 9:30 AM ISTNew Jersey: Intercept Pharmaceuticals Inc will resubmit its application for approval of its therapy for a chronic liver disease to the U.S. Food and...
Zydus initiates phase 2b, 3 adaptive pivotal clinical trial of Saroglitazar Mg Ruchika Sharma10 Dec 2021 4:33 PM ISTAhmedabad: Zydus, a discovery based, global pharmaceutical company today announced that it has received permission from the United States Food and...
Zydus Cadila Saroglitazar Mg gets Orphan Drug Designation from EMA Ruchika Sharma22 July 2021 3:17 PM ISTSaroglitazar Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gamma dual agonist.
Zydus Cadila gets USFDA Orphan Drug Designation for Saroglitazar Mg to treat PBC Ruchika Sharma29 Jan 2021 12:11 PM ISTSaroglitazar Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gamma dual agonist.
Zydus Cadila Saroglitazar secures USFDA Fast Track Designation to treat Primary Biliary Cholangitis Ruchika Sharma10 Dec 2020 12:27 PM ISTAhmedabad: Drugmaker, Zydus Cadila, has recently announced that United States Food and Drug Administration (USFDA) has granted "Fast Track...
Zydus to present PBC, NASH clinical trial data of Saroglitazar Mg Ruchika Sharma3 Nov 2020 1:00 PM ISTAhmedabad: Zydus, a discovery based, global pharmaceutical company, has recently announced that a Late-Breaker Oral Presentation and two Poster...
Cadila Pharma launches generic version of Ocaliva to treat Primary Biliary Cholangitis Ruchika Sharma9 Sept 2020 3:18 PM ISTObetocad is available in 5 mg and 10 mg tablets in packs of 10 tablets.
Dr Reddy's Labs launches generic Ocaliva in India Ruchika Sharma20 May 2020 12:17 PM ISTDr Reddy's FXRâ„¢ is available in strengths of 5mg and 10mg tablets
